Warren B Kanders

CEO Kanders sold 75,000 shares ($2,068,000) across two tranches; stock down 43.5% from 52-week high at $27.53 current price.

Warren B Kanders, CEO and Chairman, executed two separate sales totaling 75,000 shares (75.0K shares) for $2,068,000.00 across June 18–22, 2026, at a blended average price of $27.57, reducing his holdings by 0.8% to 9,617,039 shares (9.62M shares). The sales occurred as CDRE's stock has declined 43.5% from its 52-week high of $48.76 and is down 9.2% over the prior 30 days and 14.6% over 90 days—a period of material weakness. Examining his prior 5 trades at CDRE, none of the 3 measurable 90-day outcomes from prior sells were well-timed (timing pattern: 0 of 3), and his most recent two sales on 2026-03-23 and 2026-03-20 showed negative 30-day returns of -7.3% and -0.2% respectively, suggesting recent sales have not preceded further declines. His broader track record across all tickers shows a 64.29% well-timed sell rate (16 prior sells), but the same-ticker pattern at CDRE—where 0 of 3 measurable outcomes favored the sell timing—does not align with that cross-ticker performance, warranting scrutiny of whether this particular seller's actions at this name track his demonstrated effectiveness elsewhere.

CEO Warren B Kanders sells 225,000 CDRE shares for $6,539,000.00 over 3 days; stock down -42.2% from 52-week high.

Warren B Kanders, CEO and chairman, executed 3 separate sales totaling 225,000 shares for $6,539,000.00 at prices ranging from $28.19 to $30.03, reducing his holdings by 2.3% to 9,692,039 shares. The current stock price of $28.17 sits -42.2% below the 52-week high of $48.76, and the company trades at a P/E of 32.76 despite recent quarterly revenue of $155,429,000.00 and net income of $1,975,000.00. Among his prior 5 trades at CDRE, none showed negative 90-day returns (the signal of well-timed selling), with measurable outcomes showing mixed results: the two most recent prior sales in March 2026 each recorded -7.3% and -0.2% 30-day returns respectively, while earlier 2025 sales showed positive returns.

CEO Warren Kanders sold 200,000 shares of CDRE for $6,333,000.00 across 2 trades; stock now -30.8% from 52-week high

CEO and Chairman Warren B. Kanders executed 2 separate sales totaling 200,000 shares (200.0K shares) for $6,333,000.00 on 2026-03-20 and 2026-03-23 at an average of $31.66, reducing his holdings by 2.0% from 10,117,039 to 9,917,039 shares post-transaction. The sales occurred during a period of pronounced stock weakness: the stock is currently -30.8% from its 52-week high of $46.07 and has declined -28.0% over the prior 30 days. His 16 prior cross-ticker sales carry a 56.25% well-timed rate with an average 90-day return of -1.9%, indicating modest but genuine historical accuracy in sell timing. At CDRE specifically, prior sales show mixed outcomes: his 5 prior trades at this ticker produced only 1 well-timed outcome at the 90-day mark, with recent November 2025 sales posting +3.8% to +8.2% 90-day returns (poorly timed). The latest sale occurs against a backdrop of near-term price deterioration but should be monitored against the stock's recent trajectory and valuation (P/E 25.50).

CEO Kanders sells 1.34M shares (11.7% of holdings) for $52.4M at $39.00 on 2025-11-17

KANDERS WARREN B executed 2 separate sales totaling 1,343,941 shares for $52,413,699.00, representing an 11.7% reduction in his stake at CDRE. The transactions occurred at $39.00 per share, which is $1.00 below the current price of $40.00 and 13.4% below the 52-week high of $45.11. His prior open-market trading at CDRE shows mixed timing: 3 of 5 prior sells yielded negative 90-day returns (well-timed), but 2 sales were followed by gains, indicating inconsistent execution relative to downturns. Cross-ticker, his 16 prior sells averaged a 56.25% well-timed rate with -2.1% average 90-day return, suggesting his sells have historically preceded modest declines. The company trades at a P/E of 35.71 with 17.6% annual revenue growth, reflecting a growth profile, and this large secondary sale by the CEO at near-52-week lows warrants examination of whether it signals a shift in insider conviction or reflects liquidity management unrelated to fundamental outlook.

Warren Kanders buys 289,000 shares at avg $3.24 (total $935.7K) as CLAR trades 39.6% below 52-week high

Warren Kanders, Executive Chairman, acquired 289,000 shares across 2 separate transactions on 2025-08-05 and 2025-08-06 at prices of $3.24 and $3.23, totaling $935,690.40, raising his holdings to 4,444,326 shares. The purchases occurred when the stock was trading at $3.13, down 39.6% from its 52-week high of $5.18 and down 12.3% over the prior 30 days, suggesting a directional move lower in the recent period. At the same-ticker level, Kanders' two prior purchases at CLAR (2025-06-23 and 2025-06-20) posted 30-day returns of 14.7% and 2.6% respectively, though neither has yet recorded a measurable 90-day outcome. His cross-ticker buying track record shows 2 prior buys with an average 30-day return of 8.6%, indicating some historical correlation between his buy activity and near-term positive returns. However, the company fundamentals are challenged: CLAR posted revenue of $55,247,000.00 with a net loss of $8,434,000.00 in the latest quarter, annual revenue contracted 7.6% year-over-year, and the firm was unprofitable over its most recent full fiscal year, creating a backdrop of deteriorating operational performance that tempers the significance of insider accumulation at a heavily discounted price point.

CDRE CEO Warren Kanders sells 25,000 shares at $32.78; stock now $32.97, off 18.0% from 52-week high.

Warren Kanders sold 25,000 shares on 2025-06-23 at $32.78, reducing his stake from 10.24M to 10.22M shares (a 0.2% reduction). The sale occurred near current price levels ($32.97) but with the stock 18.0% below its 52-week high of $40.22, suggesting the transaction came after a significant pullback from peak valuation. Kanders' cross-ticker track record shows 18 prior sells with a 90-day well-timed rate of 25.00%, indicating his historical sells have typically been poorly timed overall. At CDRE specifically, Kanders has executed 5 consecutive sales within three weeks (2025-05-30 through 2025-06-23), though measurable outcomes remain unavailable for all five transactions. The company's fundamentals remain solid—revenue of $130.1M, net income of $9.2M, and 17.6% annual revenue growth—but the P/E of 34.71 positions the stock above historical averages for valuation. The sustained selling pattern warrants tracking to determine whether it reflects operational constraints, portfolio rebalancing, or shifts in Kanders' conviction regarding the company's near-term trajectory.

Executive Chairman Kanders bought 11,399 shares at $3.48–$3.50 avg; stock -47.4% from 52-week high, company unprofitable.

Warren Kanders purchased 11,399 shares in 2 separate transactions totaling $39,686.54 on 2025-06-20 and 2025-06-23, adding 0.3% to his 4.16M-share position. Clarus Corp is unprofitable with a $-5.2M net loss in its most recent full fiscal year and -7.6% annual revenue growth, while trading 47.4% below its 52-week high of $6.73. Kanders' cross-ticker track record shows 20 prior open-market sells with a well-timed rate of 33.33%, indicating he has historically struggled with timing; his average 90-day return after those sales was +3.6%, suggesting his prior sells preceded stock gains he did not capture. The modest size of this purchase relative to his existing position, combined with deteriorating fundamentals and depressed valuation, provides limited evidence of conviction.

CDRE CEO Kanders sells 100,000 shares across 2 transactions for $3,348,000.00, reducing stake by 1.0%

KANDERS WARREN B, CEO and Chairman of Cadre Holdings, executed 2 separate sales totaling 100,000 shares for $3,348,000.00 at a blended average price of $33.48. The stock currently trades at $32.79, down 18.5% from its 52-week high of $40.22. This sale reduces Kanders' post-transaction holdings to 10,241,192 shares from 10,341,192 shares, a 1.0% reduction. Notably, Kanders has engaged in 5 prior sales at CDRE within the past month (2025-05-28 through 2025-06-23), suggesting a pattern of regular liquidation. His broader cross-ticker track record shows 18 prior sells with a poorly-timed 90-day outcome rate (average 90d return of +3.6%, meaning the stock typically rose after his sales), though same-ticker performance at CDRE is not yet measurable. The combination of sustained sales activity and selling into a stock that remains above the current price—despite trading well below its recent high—warrants observation.

CEO Kanders sold 125,000 CDRE shares for $4.2M in two transactions, reducing stake by 1.2% amid recent high activity.

CEO and Chairman Warren B. Kanders executed 2 separate sales totaling 125,000 shares for $4,200,750.00 at an average price of $33.61, reducing his post-transaction holdings to 10.34M shares from 10.47M shares. This sale follows five additional sales at CDRE within a 10-day window (May 22–June 3), suggesting sustained liquidity action during a period when the stock has appreciated 14.7% over 30 days but remains 15.6% below its 52-week high. His cross-ticker track record shows 20 prior sales with a 100.00% well-timed rate at the 90-day mark (average 90d return -4.6%), though outcomes are not yet measurable for his recent CDRE sales. The frequency and scale of these recent open-market dispositions warrant investor attention, particularly given his substantial remaining stake of 10.34M shares and the company's strong fundamentals (revenue $130.1M, net income $9.2M, P/E 35.75).

CDRE CEO Kanders sold 50,000 shares at $32.75 on 2025-05-30; stock up 13.0% in 30 days but -16.5% from 52-week high.

Warren B. Kanders, CEO and Chairman of Cadre Holdings, sold 50,000 shares at $32.75 on 2025-05-30, reducing his holdings from 10.52M to 10.47M shares. The sale represents a minimal reduction of -0.5% of pre-transaction holdings. Context is mixed: the stock has gained 13.0% over the past 30 days and currently trades at $33.59, but remains 16.5% below its 52-week high of $40.22. Kanders' cross-ticker track record shows strong timing discipline (100.00% well-timed rate on 20 prior sells), though this is the fifth consecutive sale at CDRE within an 12-day window (May 22–June 3), and the outcomes on those earlier May trades are not yet measurable. The company's fundamentals appear solid: annual revenue growth of 17.6%, net income of $9.2M on $130.1M in latest quarterly revenue, though the P/E of 35.36 reflects a premium valuation.